share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:擬議出售證券
美股SEC公告 ·  05/14 16:33

Moomoo AI 已提取核心訊息

Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 20,054 Class A shares of the company, with an aggregate market value of $202,934.74, on 05/14/2024. These shares were originally acquired on 09/01/2016 as founders shares, a form of compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 94,503 shares were sold for gross proceeds of $984,984.41.
Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 20,054 Class A shares of the company, with an aggregate market value of $202,934.74, on 05/14/2024. These shares were originally acquired on 09/01/2016 as founders shares, a form of compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 94,503 shares were sold for gross proceeds of $984,984.41.
Recursion Pharmicals, Inc.董事布萊克·博格森定於2024年5月14日出售該公司的20,054股A類股票,總市值爲202,934.74美元。這些股票最初於2016年1月9日作爲創始人股票收購,這是發行人補償的一種形式。此次計劃出售是在過去三個月進行的一系列交易之後進行的,共出售了94,503股股票,總收益爲984,984.41美元。
Recursion Pharmicals, Inc.董事布萊克·博格森定於2024年5月14日出售該公司的20,054股A類股票,總市值爲202,934.74美元。這些股票最初於2016年1月9日作爲創始人股票收購,這是發行人補償的一種形式。此次計劃出售是在過去三個月進行的一系列交易之後進行的,共出售了94,503股股票,總收益爲984,984.41美元。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息